Data-lock may also include data from some trial patients that they see as completed. It does not mean that all current patients will be on data lock.
Remember that Ph1 morphed to Ph2 following a dose escalation study in Her-Vaxx gastric cancer patients. LOS is important. This data-lock may be all patients from Ph1, the time frame would make sense & as others have said, for LOS, the longer the news, the better the result.
Adverse effects & QOL is important for Cancer treatment also. if you want to put that into perspective, have a look at some Keytruda trial results. 2 months extra LOS with some pretty nasty A/Es on top of cancer symptoms...
Data-lock may mean we will receive some news very soon on LOS from longer term patients on Her-Vaxx Ph1. It had to happen some time. Hopefully some good news then.
Media Thread, page-37
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $505.0M | |||
| Open | High | Low | Value | Volume |
| 7.0¢ | 7.1¢ | 6.8¢ | $1.427M | 20.55M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 57517 | 6.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.0¢ | 667419 | 9 |
View Market Depth
| Last trade - 16.10pm 21/05/2024 (20 minute delay) ? |
|
|||||
|
Last
6.9¢ |
Change
0.000 ( 0.29 %) |
||||
| Open | High | Low | Volume | ||
| 6.9¢ | 7.1¢ | 6.8¢ | 7149293 | ||
| Last updated 15.59pm 21/05/2024 ? | |||||
| IMU (ASX) Chart |